Results of the September 2019 Impact Grants Competition

We are pleased to announce the results of the September 2019 Impact Grants competition. This program has been designed to accelerate and focus the knowledge gained from scientific findings, in the short or long term, into outcomes that will significantly advance understanding of cancer and improve scientific knowledge, which will result in optimized patient care, improved cancer treatment or reduced cancer burden. Below is a listing of newly awarded Canadian Cancer Society (CCS) Impact Grants.

9 Canadian Cancer Society Impact Grants have been approved – 29% of all full proposals received. 104 Letters of Intent were submitted to the competition and following a scientific review 34 of these were invited to submit full applications, and 31 were received. Grants are valued at up to $1.5M over a 5-year term. These 9 new grants represent an investment of over $13.2 million. One grant has been generously supported by the Lotte & John Hecht Memorial Foundation.

Abstracts of awarded grants

Program Statistics

Please note:

  • Amounts listed below represent the total dollars awarded by grant year and may include funds for salaries, supplies, and/or equipment.
  • The start date for these grants is January 1, 2020.
  • Only the Principal Investigator is named in this listing. Co-Principal Investigators, Co-Applicants and/or Additional Authors may also be associated with these grants.

Note Carefully:

Although every effort has been made to ensure the accuracy of the listing below, this list does not constitute an "official" notification.

Successful applicants will be informed, in writing, with an official Notification of Award giving the details pertaining to their grant.

Applicant
Institution
Title
Award
Bhatia, Mick*
McMaster University
Targeting responsive microenvironment to prevent relapse of human acute myeloid leukemia
2019/2020 :  $300,000
2020/2021 :  $300,000
2021/2022 :  $300,000
2022/2023 :  $300,000
2023/2024 :  $300,000
Dick, John*
Princess Margaret Cancer Centre UHN
Cellular and molecular mechanisms underlying AML initiation and evolution
2019/2020 :  $300,000
2020/2021 :  $300,000
2021/2022 :  $300,000
2022/2023 :  $300,000
2023/2024 :  $300,000
Dirks, Peter
The Hospital for Sick Children
Reimagining glioblastoma as a consequence of aberrant neural tissue repair
2019/2020 :  $300,000
2020/2021 :  $300,000
2021/2022 :  $300,000
2022/2023 :  $300,000
2023/2024 :  $300,000
Hieter, Philip
University of British Columbia
Setting a trap for cancer cells: high throughput screening for protein trapping synthetic lethal targets for cancer therapy
2019/2020 :  $250,000
2020/2021 :  $250,000
2021/2022 :  $250,000
2022/2023 :  $250,000
2023/2024 :  $250,000
Ikura, Mitsuhiko*
Princess Margaret Cancer Centre UHN
Translating discoveries in RAS mechanistic biology into cancer therapeutics
2019/2020 :  $300,000
2020/2021 :  $300,000
2021/2022 :  $300,000
2022/2023 :  $300,000
2023/2024 :  $300,000
Muller, William
McGill University
Targeting EZH2 in breast cancer: role of epigenetic modification in modulating cross talk between tumour epithelial cell and its microenvironment
2019/2020 :  $299,932
2020/2021 :  $299,932
2021/2022 :  $299,932
2022/2023 :  $299,932
2023/2024 :  $299,932
Routy, Bertrand
Centre de recherche du CHUM
Fecal microbial transplantation to increase immunotherapy activity in melanoma and non small cell lung cancer
(supported by the Lotte & John Hecht Memorial Foundation)
2019/2020 :  $300,000
2020/2021 :  $300,000
2021/2022 :  $300,000
2022/2023 :  $300,000
2023/2024 :  $289,100
Wrana, Jeffrey
Mount Sinai Hospital
Revival stem cells in colorectal cancer
2019/2020 :  $300,000
2020/2021 :  $300,000
2021/2022 :  $300,000
2022/2023 :  $300,000
2023/2024 :  $300,000
Wyatt, Alexander
University of British Columbia
Practical genomic stratification to enable tailored treatment of DNA repair defective prostate cancer
2019/2020 :  $300,000
2020/2021 :  $300,000
2021/2022 :  $300,000
2022/2023 :  $300,000
2023/2024 :  $300,000
*Renewal Grant. Last modified on: June 2, 2020